Source: Clinical and Experimental Dermatology, Volume 47, Issue 12, 1 December 2022, Pages 2269–2272

Objective: To evaluate the effects of MitoHeal® supplementation on skin quality and self-perceived skin satisfaction in healthy adults

Study Design:

Participants: 40 adults (mean age 44.65 years)

Dosage: 500mg、1000mg dosages of cognitaven® or placebo

Study Type: randomized, double-blind, placebo-controlled study

Duration: 30 days

Results:  MitoHeal supplementation resulted in improvements in skin quality and patient satisfaction from Day 0 to Day 30, with a dose–response relationship.